{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:06:14Z","timestamp":1762376774538,"version":"build-2065373602"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013330","name":"Society of Cardiovascular Anesthesiologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1053\/j.jvca.2020.07.048","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T12:28:43Z","timestamp":1595334523000},"page":"406-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Pharmacokinetic and Pharmacodynamic Investigation of an \u03b5-Aminocaproic Acid Regimen Designed for Cardiac Surgery With Cardiopulmonary Bypass"],"prefix":"10.1053","volume":"35","author":[{"given":"Erik R.","family":"Strauss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyes","family":"Dahmane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda","family":"Judd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittney","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Gammie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Mazzeffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8348-4295","authenticated-orcid":false,"given":"Jogarao V.S.","family":"Gobburu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi A.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2020.07.048_bib0001","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2020.07.048_bib0002","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/j.jvca.2015.12.003","article-title":"Epsilon-aminocaproic acid has no association with thromboembolic complications, renal failure, or mortality after liver transplantation","volume":"30","author":"Nicolau-Raducu","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2020.07.048_bib0003","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/bja\/aeu459","article-title":"Population pharmacokinetics of \u03f5-aminocaproic acid in adolescents undergoing posterior spinal fusion surgery","volume":"114","author":"Stricker","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2020.07.048_bib0004","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0022-5223(19)35778-2","article-title":"The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: A double-blind randomized study","volume":"95","author":"Vander Salm","year":"1988","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2020.07.048_bib0005","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jamcollsurg.2005.10.001","article-title":"A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery","volume":"202","author":"Kikura","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1053\/j.jvca.2020.07.048_bib0006","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1213\/00000539-199712000-00008","article-title":"The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery","volume":"85","author":"Slaughter","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2020.07.048_bib0007","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00000542-199908000-00017","article-title":"The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting","volume":"91","author":"Troianos","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2020.07.048_bib0008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1213\/ane.0b013e3181a40b5d","article-title":"The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: A randomized, double-blind, placebo-controlled, noninferiority trial","volume":"109","author":"Greilich","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2020.07.048_bib0009","first-page":"15","article-title":"The absorption, distribution, and excretion of epsilon-aminocaproic acid following oral or intravenous administration to man","volume":"59","author":"McNicol","year":"1962","journal-title":"Transl Res"},{"key":"10.1053\/j.jvca.2020.07.048_bib0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/clpt.1984.48","article-title":"Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects","volume":"35","author":"Frederiksen","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.jvca.2020.07.048_bib0011","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1749-6632.1968.tb20322.x","article-title":"Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA","volume":"146","author":"Andersson","year":"1968","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.jvca.2020.07.048_bib0012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MBC.0b013e328010a359","article-title":"\u03b5-Aminocaproic acid inhibition of fibrinolysis in vitro: Should the \u2018therapeutic\u2019 concentration be reconsidered?","volume":"18","author":"Nielsen","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.jvca.2020.07.048_bib0013","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0888-6296(89)92642-2","article-title":"Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery","volume":"3","author":"Tanaka","year":"1989","journal-title":"J Cardiothorac Anesth"},{"key":"10.1053\/j.jvca.2020.07.048_bib0014","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/1053-0770(94)90055-8","article-title":"Assessment of coagulation factor activation during cardiopulmonary bypass with a new monoclonal antibody","volume":"8","author":"Journois","year":"1994","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2020.07.048_bib0015","doi-asserted-by":"crossref","first-page":"19658","DOI":"10.1016\/S0021-9258(17)45422-6","article-title":"Interaction of plasminogen and fibrin in plasminogen activation","volume":"265","author":"Wu","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1053\/j.jvca.2020.07.048_bib0016","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2010-06-290338","article-title":"The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: Kinetic and microscopic studies","volume":"117","author":"Longstaff","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2020.07.048_bib0017","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1182\/blood-2002-08-2400","article-title":"Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass","volume":"101","author":"Chandler","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2020.07.048_bib0018","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0003-4975(00)02229-3","article-title":"Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: Efficiency, safety and cost","volume":"71","author":"Ray","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2020.07.048_bib0019","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.thromres.2003.11.006","article-title":"Secretion of tissue plasminogen activator and plasminogen activator inhibitor 1 during cardiopulmonary bypass","volume":"112","author":"Chandler","year":"2003","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2020.07.048_bib0020","first-page":"583","article-title":"Plasmin generation and D-dimer formation during cardiopulmonary bypass","volume":"15","author":"Chandler","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.jvca.2020.07.048_bib0021","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/00000542-199906000-00019","article-title":"Pharmacokinetics of \u03b5-aminocaproic acid in patients undergoing aortocoronary bypass surgery","volume":"90","author":"Butterworth","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2020.07.048_bib0022","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/trf.15253","article-title":"Impact of intraoperative high-volume autologous blood collection on allogeneic transfusion during and after cardiac surgery: A propensity score matched analysis","volume":"59","author":"Henderson","year":"2019","journal-title":"Transfusion"},{"key":"10.1053\/j.jvca.2020.07.048_bib0023","first-page":"3","article-title":"PuMaS: A simulation engine for drug development and clinical therapeutics in Julia, abstracts for the Ninth American Conference on Pharmacometrics (ACoP9)","author":"Rackacukas","year":"2018","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1053\/j.jvca.2020.07.048_bib0024","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.5858\/arpa.2012-0296-CP","article-title":"D-dimer: Simple test, tough problems","volume":"137","author":"Olson","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.jvca.2020.07.048_bib0025","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.CIR.96.3.761","article-title":"Clearance of tissue plasminogen activator (TPA) and TPA\/plasminogen activator inhibitor type 1 (PAI-1) complex: Relationship to elevated TPA antigen in patients with high PAI-1 activity levels","volume":"96","author":"Chandler","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2020.07.048_bib0026","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00000542-200208000-00016","article-title":"Pharmacokinetics of tranexamic acid during cardiopulmonary bypass","volume":"97","author":"Dowd","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2020.07.048_bib0027","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/ALN.0000000000000616","article-title":"Pharmacokinetics of \u03b5-aminocaproic acid in neonates undergoing cardiac surgery with cardiopulmonary bypass","volume":"122","author":"Eaton","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2020.07.048_bib0028","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1606424","article-title":"Tranexamic acid in patients undergoing coronary-artery surgery","volume":"376","author":"Myles","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2020.07.048_bib0029","first-page":"248","article-title":"Epsilon-aminocaproic acid plasma levels during cardiopulmonary bypass","volume":"85","author":"Bennett-Guerrero","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2020.07.048_bib0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ahj.2019.09.010","article-title":"Outcome impact of different tranexamic acid regimens in cardiac surgery with cardiopulmonary bypass (OPTIMAL): Rationale, design, and study protocol of a multicenter randomized controlled trial","volume":"222","author":"Shi","year":"2020","journal-title":"Am Heart J"},{"key":"10.1053\/j.jvca.2020.07.048_bib0031","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/ALN.0b013e3182a443e8","article-title":"Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass","volume":"120","author":"Sigaut","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2020.07.048_bib0032","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1749-8090-6-138","article-title":"Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: A randomized double-blind, dose-dependent, phase IV clinical trial","volume":"6","author":"Jimenez","year":"2011","journal-title":"J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2020.07.048_bib0033","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/icvts\/ivv134","article-title":"What dose of tranexamic acid is most effective and safe for adult patients undergoing cardiac surgery?","volume":"21","author":"Hodgson","year":"2015","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1053\/j.jvca.2020.07.048_bib0034","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12630-011-9618-z","article-title":"Seizures following cardiac surgery: The impact of tranexamic acid and other risk factors","volume":"59","author":"Manji","year":"2012","journal-title":"Can J Anaesth"},{"key":"10.1053\/j.jvca.2020.07.048_bib0035","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1172\/JCI63375","article-title":"Tranexamic acid concentrations associated with human seizures inhibit glycine receptors","volume":"122","author":"Lecker","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jvca.2020.07.048_bib0036","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/jcp.32.8.822","article-title":"Fibrinolytic activity of tissue surfaces during surgery","volume":"32","author":"Davies","year":"1979","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.jvca.2020.07.048_bib0037","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1213\/01.ANE.0000108489.88613.2C","article-title":"Reducing hemostatic activation during cardiopulmonary bypass: A combined approach","volume":"98","author":"Eisses","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2020.07.048_bib0038","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1053-0770(05)80008-4","article-title":"Significance of D-dimer concentrations during and after cardiopulmonary bypass","volume":"10","author":"Comunale","year":"1996","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2020.07.048_bib0039","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1213\/ANE.0b013e3181fc6df0","article-title":"Enhanced thrombin generation after cardiopulmonary bypass surgery","volume":"112","author":"Lison","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2020.07.048_bib0040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.thromres.2013.12.017","article-title":"Measurement of thrombin generation intra-operatively and its association with bleeding tendency after cardiac surgery","volume":"133","author":"Bosch","year":"2014","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2020.07.048_bib0041","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1055\/s-0038-1657680","article-title":"Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin","volume":"78","author":"Ray","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2020.07.048_bib0042","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0049-3848(01)00379-6","article-title":"Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery","volume":"104","author":"Kojima","year":"2001","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2020.07.048_bib0043","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0022-5223(96)70112-5","article-title":"Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid","volume":"112","author":"Vander Salm","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2020.07.048_bib0044","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/jth.12078","article-title":"The incidence and magnitude of fibrinolytic activation in trauma patients","volume":"11","author":"Raza","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2020.07.048_bib0045","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1055\/s-0038-1650684","article-title":"More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT","volume":"76","author":"Despotis","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2020.07.048_bib0046","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood.V96.8.2793","article-title":"Analysis of fibrin formation and proteolysis during intravenous administration of ancrod","volume":"96","author":"Dempfle","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2020.07.048_bib0047","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.thromres.2015.06.028","article-title":"The role of activated coagulation factor XII in overall clot stability and fibrinolysis","volume":"136","author":"Konings","year":"2015","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2020.07.048_bib0048","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1182\/blood.V48.4.531.531","article-title":"Fibrinolysis in normal plasma and blood: Evidence for significant mechanisms independent of the plasminogen-plasmin system","volume":"48","author":"Moroz","year":"1976","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2020.07.048_bib0049","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1042\/BST20180211","article-title":"Structural studies of plasmin inhibition","volume":"47","author":"Wu","year":"2019","journal-title":"Biochem Soc Trans"},{"key":"10.1053\/j.jvca.2020.07.048_bib0050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0003-4975(01)02819-3","article-title":"Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit","volume":"72","author":"Ray","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2020.07.048_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17100","article-title":"The CRASH-2 trial: A randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1053\/j.jvca.2020.07.048_bib0052","doi-asserted-by":"crossref","first-page":"100","DOI":"10.12688\/wellcomeopenres.14722.1","article-title":"Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): A single-centre, randomised, double-blind, placebo-controlled trial","volume":"3","author":"Shakur-Still","year":"2018","journal-title":"Wellcome Open Res"},{"key":"10.1053\/j.jvca.2020.07.048_bib0053","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archsurg.2011.287","article-title":"Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study","volume":"147","author":"Morrison","year":"2012","journal-title":"Arch Surg"},{"key":"10.1053\/j.jvca.2020.07.048_bib0054","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1001\/jama.1978.03290220080026","article-title":"Seizure after infusion of aminocaproic acid","volume":"240","author":"Feffer","year":"1978","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2020.07.048_bib0055","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/106002808902301008","article-title":"Convulsions induced by aminocaproic acid infusion","volume":"23","author":"Rabinovici","year":"1989","journal-title":"DICP"},{"key":"10.1053\/j.jvca.2020.07.048_bib0056","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1053\/j.jvca.2013.04.003","article-title":"Comparison of epsilon aminocaproic acid and tranexamic acid in thoracic aortic surgery: Clinical efficacy and safety","volume":"27","author":"Makhija","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2020.07.048_bib0057","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1182\/blood-2017-06-789032","article-title":"Endogenous fibrinolysis facilitates clot retraction in vivo","volume":"130","author":"Samson","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2020.07.048_bib0058","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0003-4975(97)01424-0","article-title":"High-dose epsilon-aminocaproic acid versus aprotinin: antifibrinolytic efficacy in first-time coronary operations","volume":"65","author":"Eberle","year":"1998","journal-title":"Ann Thorac Surg"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077020307217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077020307217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:49:45Z","timestamp":1760946585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077020307217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1053077020307217"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2020.07.048","relation":{},"ISSN":["1053-0770"],"issn-type":[{"type":"print","value":"1053-0770"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Pharmacokinetic and Pharmacodynamic Investigation of an \u03b5-Aminocaproic Acid Regimen Designed for Cardiac Surgery With Cardiopulmonary Bypass","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2020.07.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}